Eli Lilly and Co (USD)
LLY
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range119.58 | 120.71
52-Wk Range101.36 | 132.13
Last Close119.64
Mkt Cap (m)114,870.05
Dividend yield2.16%
ISINUS5324571083
Volume2,462,830
Exchange VenueNYS

Company Profile

Eli Lilly and Co is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. It discovers, develops, manufactures, and sells human pharmaceutical products and animal health products.

Key Information
Price/Earning26.59
Price/Book34.01
Price/Sales4.62
P/CF26.64
Rev Growth (3 year avg)7.15
EPS Growth (3 year avg)0.11
Operating Margin % 26.18
Net Margin %13.16
Return on Equity30.18
Debt/Equity1.30

Legal Documents

Prospectus
en 30/10/2019
Annual Report
en 31/12/2018

Financials

Income Statement
USD201320142015201620172018
Revenue (m)23,11319,61619,95921,22222,87124,556
Operating Income (m)5,5483,3293,5923,8714,9316,429
Net Income (m)4,6852,3912,4082,738-2043,232
Basic EPS4.332.232.272.59-0.193.14
Avg. Diluted Shares Outstanding (m)1,0851,0741,0661,0621,0521,034
Balance Sheet
USD201320142015201620172018
Current Assets (m)13,10512,18012,57415,10119,20220,550
Non Current Assets (m)22,14424,99822,99523,70525,77923,359
Total Assets (m)35,24937,17835,56938,80644,98143,908
Current Liabilities (m)8,91711,2088,23010,98714,53611,888
Total Liabilities (m)------
Total Equity (m)17,63115,37314,57114,00811,5929,829
Cash Flows
USD201320142015201620172018
Operating Cash Flows (m)5,7354,3672,7734,8515,6165,525
Capital Expenditure (m)-1,093-1,566-1,626-1,092-2,164-3,018
Figures are quoted in USD unless stated otherwise
0.00 (0.00%)
$
119.64
Last Price